Disbiosis: El freno oculto del GLP-1 Cuando el microbioma intestinal est desequilibrado (disbiosis), las bacterias productoras de AGCC disminuyen
The number of bariatric surgeries fell 8.7% in the last six months of 2023 compared with the same period in 2022 while the number of patients prescribed GLP-1 drugs rose 105.7% in the same time frame, according to a study in JAMA
Safety and Follow-Up Sourcing, Oversight, Results, and Monitoring Medical screening: A responsible plan starts with goals, symptoms, health history, medications, risk factors, and treatment priorities
Roughly 10% of U.S
Conclusion Research shows GLP-1 receptor agonist therapy slightly increases thyroid cancer risk, though the absolute risk stays low at
Requires sustained methyl donor concentrations above baseline for 4872 hours to produce measurable increases in lipid export from hepatocytes